Irvine Clinical Research
The Research Nurse at Healthy Brain Clinic in Long Beach supports clinical drug trials focused on neurology, psychiatry, obesity, and particularly Alzheimer’s Disease prevention and treatment. The role is embedded within a large, specialized clinical research network conducting investigational infusion-based studies in older adults. The nurse will work closely with a team of clinicians in a dedicated research setting rather than a traditional hospital or outpatient clinic. This position contributes directly to the development of new, FDA-track therapies through careful execution of study protocols and documentation.
Headquarters
Irvine, California, United States
Company Size
11-50 employees
Founded
1978
Irvine Clinical Research is the largest independent memory research center on the West Coast, located in Irvine, California. The organization conducts clinical trials focused primarily on memory loss and psychiatry, including depression research, recruiting qualified participants and providing all study-related medical care and medications at no cost. It serves both participants seeking research opportunities and sponsors looking for clinical research solutions.
Alzheimer's drug trials target older Californians. Do they understand what they're signing up for?
Jul 10, 2023
FDA approves new Kisunla dosing regimen to lower ARIA-E risk
Jul 11, 2025
Bisexual women may face a higher heart disease risk, new research suggests
Mar 1, 2023
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Irvine Clinical Research.
Irvine Clinical Research didn’t post a salary, so this is our estimate from similar listings.
Inside the plan to diagnose Alzheimer’s in people with no memory problems — and who stands to benefit
Feb 14, 2024